YahooOctober 20, 2026 at 12:44 PM NY7 Days Ago
Eli Lilly Gains 4.6% as Goldman Sachs Lifts Price Target to $1,413
Key TakeawaysEli Lilly shares rose 4. 6% today to a record high after Goldman Sachs raised its price target to $1,413 from $1,371 and kept its Buy rating.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
